Premise: Despite strong opposition from organizations dedicated to the protection of developmental sanctity of unborn children, from groups devoted to the protection of family traditions, and from task forces committed to the preservation of racial purity, the new method (license purchased by the pharmaceutical giant Robots Healthcare) began to gain tremendous popularity, especially since it was introduced onto the market in conjunction with an attractive credit plan, offered by HSBBC.

Hypothesis: Robots Healthcare bought the license for the new method at a high price of $5 billion.
Relation: neutral